In order to examine the possibility that changes in Nrf-2 protein expression in GSCs and non-GSCs glioma cells might be due to differences in Keap1/Nrf-2 interaction, co-immunoprecipitation was performed to examine Keap1/Nrf-2 interaction status. This evidence concerns the gene KEAP1 and central nervous system cancer.